Cargando…
Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478613/ https://www.ncbi.nlm.nih.gov/pubmed/34400587 http://dx.doi.org/10.5045/br.2021.2020181 |
| _version_ | 1784576100012130304 |
|---|---|
| author | Cecyn, Karin Zattar Marques, Mariana Oliveira Rodrigues, Milena Almendra Brito, Fábio Nascimento Baiocchi, Otávio Cesar Carvalho Guimarães |
| author_facet | Cecyn, Karin Zattar Marques, Mariana Oliveira Rodrigues, Milena Almendra Brito, Fábio Nascimento Baiocchi, Otávio Cesar Carvalho Guimarães |
| author_sort | Cecyn, Karin Zattar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8478613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84786132021-10-09 Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report Cecyn, Karin Zattar Marques, Mariana Oliveira Rodrigues, Milena Almendra Brito, Fábio Nascimento Baiocchi, Otávio Cesar Carvalho Guimarães Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021-09-30 2021-09-30 /pmc/articles/PMC8478613/ /pubmed/34400587 http://dx.doi.org/10.5045/br.2021.2020181 Text en © 2021 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Cecyn, Karin Zattar Marques, Mariana Oliveira Rodrigues, Milena Almendra Brito, Fábio Nascimento Baiocchi, Otávio Cesar Carvalho Guimarães Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title | Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title_full | Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title_fullStr | Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title_full_unstemmed | Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title_short | Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report |
| title_sort | clinical course of covid-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll) under ibrutinib therapy: a case report |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478613/ https://www.ncbi.nlm.nih.gov/pubmed/34400587 http://dx.doi.org/10.5045/br.2021.2020181 |
| work_keys_str_mv | AT cecynkarinzattar clinicalcourseofcovid19inapatientwithrefractorychroniclymphocyticleukemiasmalllymphocyticlymphomacllsllunderibrutinibtherapyacasereport AT marquesmarianaoliveira clinicalcourseofcovid19inapatientwithrefractorychroniclymphocyticleukemiasmalllymphocyticlymphomacllsllunderibrutinibtherapyacasereport AT rodriguesmilenaalmendra clinicalcourseofcovid19inapatientwithrefractorychroniclymphocyticleukemiasmalllymphocyticlymphomacllsllunderibrutinibtherapyacasereport AT britofabionascimento clinicalcourseofcovid19inapatientwithrefractorychroniclymphocyticleukemiasmalllymphocyticlymphomacllsllunderibrutinibtherapyacasereport AT baiocchiotaviocesarcarvalhoguimaraes clinicalcourseofcovid19inapatientwithrefractorychroniclymphocyticleukemiasmalllymphocyticlymphomacllsllunderibrutinibtherapyacasereport |